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Background
ARV resistance in children with first-line ARV treat-
ment failure in Vietnam is unknown because antiretro-
viral therapy (ART) has been available on a large scale
only since Sept 2005 and resistance testing is not widely
performed. We characterize patterns of mutations to
identify common resistance patterns for choosing the
second-line regimens in Ho Chi Minh City.
Methods
54 HIV-infected children were identified as having sus-
pected treatment failure from June to December 2008 in
HCMC. Selection criteria were one of the clinical or
immunological criteria defined by the Vietnam Ministry of
Health (development or recurrence of a WHO stage III or
IV condition, failure to thrive, slow growth, CD4 falling
below pretreatment value or below 50% of peak treatment
value). The genotypic test was done at Pasteur Institute
(RT-PCR Promega, DTCS Beckman Coulter) and analyzed
using Stanford University’s HIV drug resistance database.
Results
Most of children were on first line regimens: 17 (31.4%)
on D4T+3TC+NVP, 7 (13%) on D4T+3TC+EFV, 13
(24.1%) on AZT+3TC+NVP, and 8 (14.8%) on AZT
+3TC+EFV. Six patients were on NRTI-only regimens
and 3 patients were on PI-containing regimens due to
allergy or intolerance to NNRTI. Mean duration of
treatment was 15 months. Viral load was undetectable
in 14 samples (26.9%). Genotype tests results were avail-
able on 36 patients. Overall, one mutation was detected
in 34 (94.4%) patients. NRTI mutations were found in
33 (91.7%), NNRTI mutations in 25 (69.4%), and PI
mutations in 3 (8.3%). Among the NRTI mutations, at
least one Thymidine Analog Mutation (TAM) defined
as M41L, D67N, K70R, L210W, T215Y/F, and K219Q/E,
was found in 24 patients (72.7%), of which 17 (70.8%)
patients had >3 TAMs. M184V was detected in 22
(66.7%); K65R in 3 (9.1%). Combinations of TAMs
+M184V and TAMs+K65R mutations were present in
15 (45.4%) and 2 (6.1%), respectively. For NNRTI muta-
tions, Y181C was most frequent 14 (56%), followed by
G190A/S 11 (44%), K101K 7 (28%), K103N 4 (16),
V108I 3 (12%) and Y188L (8%). Only three patients with
one single PI mutation (33.3%) including M46I, L10F
and A71V were found.
Conclusions
TAMs and the M184V mutation were present in a
majority of genotypic tests. K65R and Q151M mutations
were less common. The second-line regimen TDF+3TC
+LPV/r would be more effective than ABC+DDI+LPV/r
for most children with virological failure on first-line
ARV in HCMC. More options for second-line in devel-
oping countries are needed.
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